Introduction
The period of menopause is accompanied by termination of the menstrual cycle. It is assumed to start from the 12th consecutive month of missing menstruation. In most cases, menopause occurs in the period between 40 and 50 years of age.
Aim
The objective of this present work is to present and analyze certain aspects of the menopausal symptomatic and the medication therapy in the menopause period.
Materials and Methods
A study using a direct anonymous survey was conducted on the territory of Varna Municipality during the period January – March 2018. The data collected from the survey was processed using the SPSS statistical software.
Symptoms
The transition to menopause plays an important role in the etiology of symptoms described as hot flashes, nighttime sweating, mood changes, sleep disturbance, and sexual dysfunction. Therapy Approaches
Hormone substitution therapy is an approach, which includes taking of hormones (estrogen and progesterone) for treatment of the symptoms of menopause and aging. Pharmacies offer a wide range of estrogen therapy medicinal products in the form of pills, plasters, suppositories, etc.
Natural products therapy for menopausal symptoms includes herbs and other plant and non-plant additives.
Conclusion
Menopause is a natural stage in the aging process of the female organism. We are of the opinion that successful identification of the symptoms in the transitional period to menopause, and increased awareness of mature women as regards the therapy approaches available to apply, would have a significant positive impact on women’s health and social well-being.
Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: A systematic review of its efficacy. Pharmacological Research 58 (2008) 8–14.
Carpenter JS, Neal JG. Other complementary and alternative medicine modalities: acupuncture, magnets, reflexology, and homeopathy. Am J Med 2005;118:109–17.
Carroll DG. Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 2006;73:457–64.
Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140:184–8.
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605–13.
MacLennan AH, TaylorAW,Wilson DH.Hormonetherapy use after theWomen’s Health Initiative. Climacteric 2004;7:138–42.
Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453–65.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, StefanickML, et al.,Writing Group for theWomen’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33.
The North American Menopause Society. Menopause Curriculum Study Guide. 2002. Available at: http://www.menopause.org. Accessed 10 March 2004.
